MSD has inaugurated a 2.5 lakh square feet technology centre in Hyderabad, expanding its digital, data, analytics, AI, technology and engineering capabilities in the city as Telangana seeks to position itself as a global hub for life sciences and advanced technology.
Located in HITEC City, the new centre will support MSD’s global Human Health business and form part of the company’s worldwide technology network.
The centre comes as Telangana attempts to move its life-sciences ecosystem beyond its traditional strength in manufacturing and towards advanced R&D, discovery, technology and global capability creation.
“Telangana has built a truly end-to-end life sciences ecosystem, with more than 2,000 companies spanning APIs, bulk drugs, generics, CDMO, vaccines, research and discovery,” Sridhar Babu, Telangana’s Minister for Information Technology, Electronics & Communications, Industries and Commerce and Legislative Affairs, said.
The minister said the state has attracted major global companies in recent years, with operations spanning technology, innovation and R&D.
The new centre will bring together teams working across digital, data, analytics, AI, technology and engineering. These teams will contribute to enterprise technology solutions for MSD’s global operations and collaborate with teams across geographies.
Abhishek Narayan Singh, Senior Vice President, Digital Human Health, MSD, said the centre reflects the company’s focus on building technology capabilities that can operate at global scale.
“The inauguration of our Hyderabad Technology Centre reflects MSD’s long-term commitment to building world-class digital capabilities that drive business value at scale,” Singh said.
“Hyderabad’s vibrant technology ecosystem, deep digital expertise and strong talent pool make it an ideal location for MSD, and we are grateful for the support and engagement of the Telangana government.”
The centre, he added, would bring together talent, technology and global collaboration to develop scalable solutions supporting MSD’s operations and broader healthcare mission.
Telangana currently has more than 2,000 life-sciences companies, spanning pharmaceuticals, APIs, bulk drugs, generics, CDMO, vaccines and research.
The state has also seen several global life-sciences companies expand their technology and R&D operations in recent years, including Amgen, Eli Lilly, Bristol Myers Squibb, Sanofi, Align Technology and Zoetis.
The minister also said Telangana expects to reach 100 GCCs, building on the more than 75 GCCs established in the state last year, with a target of creating 4 lakh direct and indirect high-value opportunities.
The government is also developing Bharat Future City, which includes a 2,100-acre life-sciences zone and a specialised 100-acre hub for advanced biologics.
Another initiative, the 1Bio model, is designed to provide plug-and-play access to advanced bio-foundry infrastructure, aimed at helping companies accelerate research, innovation and commercialisation.
Telangana is also seeking to strengthen the talent pipeline through institutions including CSIR-IICT, CCMB and NIPER, alongside initiatives such as the Telangana School of Life Sciences and industry-integrated PhD programmes.
The objective is to create talent capable of working across life sciences, technology and advanced R&D rather than keeping these sectors in separate silos.
For MSD, the Hyderabad centre adds another layer to its India operations, enabling local teams to contribute to enterprise technology solutions supporting the company’s global Human Health business.
The centre is expected to create opportunities for high-value technology work spanning digital transformation, data, analytics, AI and engineering.
Your reaction
Discussion
What's your take on this story?
No comments yet — be the first to share your view.